Search clinical trials for: SB-742457 35mg

Total 1341 results

GlaxoSmithKline

Completed

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Alzheimer's Disease

Australia, Italy, United States, Argentina, Germany, Spain, Czechia, Canada, Chile
GlaxoSmithKline

Completed

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

Alzheimer's Disease

Spain, Bulgaria, Korea, Republic of, Chile, Greece, Slovakia, South Africa, New Zealand, Russian Federation, Czech Republic, Austria, Poland, Croatia
GlaxoSmithKline

Completed

A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.

Alzheimer's Disease

United States
Genor Biopharma Co., Ltd.

Unknown

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Rheumatoid Arthritis

China
GlaxoSmithKline

Completed

Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Chronic Idiopathic Thrombocytopenic Purpura | Purpura, Thrombocytopenic, Idiopathic

Japan
TaiwanJ Pharmaceuticals Co., Ltd

Terminated

Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies (JKB122)

Chronic Hepatitis C

Taiwan
GlaxoSmithKline

Completed

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Lung Injury, Acute

United States
Protgen Ltd

Unknown

Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

China
Daewon Pharmaceutical Co., Ltd.

Completed

Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects

Healthy

Korea, Republic of
Timothy Roberts
Simons Foundation; Clinical Research Associates, LLC

Completed

MEG Study of Acute STX209 Effects in ASD

Autism Disorder

United States
Tisento Therapeutics

Not yet recruiting

A Phase 2b Study of Zagociguat in Patients With MELAS (PRIZM)

Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

United States, Australia, Italy, Germany, Canada, United Kingdom
Stanford University

Withdrawn

Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder

Depression | Major Depressive Disorder
Protgen Ltd

Unknown

Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure

Pancreatic Cancer

China
Pfizer

Terminated

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males

Healthy

United States
GlaxoSmithKline

Completed

SB-742457 And Donepezil In Alzheimer's Disease

Alzheimer's Disease

Bulgaria, Estonia, Chile, Russian Federation, Slovakia, Germany, Austria, United Kingdom
South China Center For Innovative Pharmaceuticals
Xiangya Hospital of Central South University

Completed

Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration (AD16)

Alzheimer's Disease

China
GlaxoSmithKline

Completed

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

Alzheimer's Disease

Bulgaria, Estonia, Korea, Republic of, Germany, Greece, Czechia, South Africa, Russian Federation, Poland, Chile, Mexico
Ascletis Pharmaceuticals Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

China
University of Minnesota

Recruiting

Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes

Cardiovascular Diseases | Type 2 Diabetes

United States
Haisco Pharmaceutical Group Co., Ltd.

Completed

Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy Volunteers

Healthy

China
GlaxoSmithKline

Completed

Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical

Completed

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

Alopecia

Korea, Republic of
GlaxoSmithKline

Completed

A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.

Schizophrenia

United Kingdom
Sangamo Therapeutics

Active, not recruiting

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX (LTFU)

Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II

United States
Medica Cor Heart Hospital

Unknown

Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS) (SBPS)

Coronary Ostium Stenosis | Myonecrosis

Bulgaria
Nguyen Thi Trieu, MD

Completed

Composition for Treating Cirrhosis and Liver Cancer (SB-1121) (SB-1121)

Cirrhosis of the Liver

Vietnam
GlaxoSmithKline

Completed

Integrated Biomarker And Imaging Study - 2

Atherosclerosis

Netherlands, Belgium, Germany, Czechia, France, Austria, Spain, Norway, Poland, Denmark, Switzerland
Pfizer

Completed

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia

Schizophrenia

United States
TWi Biotechnology, Inc.

Completed

Study of AC-201 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Taiwan
Indiana University
Eli Lilly and Company

Terminated

The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia (Beta)

Schizophrenia

United States
Boston Medical Center
National Institute of Mental Health (NIMH)

Completed

Improving HIV Prevention Skills in People With Serious Mental Illnesses

HIV/AIDS

United States
Case Comprehensive Cancer Center

Active, not recruiting

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditions

United States
Targacept Inc.

Completed

Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
GlaxoSmithKline

Completed

A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose

Inflammation | Arthritis, Rheumatoid

United Kingdom
SBPharmaceutical IND, Co., LTD

Unknown

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

Korea, Republic of
GlaxoSmithKline

Completed

Use Of SB-705498 In The Acute Treatment Of Migraine

Migraine, Acute

Australia, Netherlands, United Kingdom, Canada
GlaxoSmithKline

Completed

SB-743921 In Patients With Solid Tumors

Solid Tumor Cancer

United States
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Suspended

SY007 in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

China
GlaxoSmithKline

Terminated

Sb-705498 Rectal Pain Study

Irritable Colon

United Kingdom
GlaxoSmithKline

Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Sleep Disorders

Germany
Sangamo Therapeutics

Completed

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) (ALS)

Amyotrophic Lateral Sclerosis

United States
SBPharmaceutical IND, Co., LTD

Unknown

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer

Gastric Cancer

Korea, Republic of
SBPharmaceutical IND, Co., LTD

Unknown

Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

Korea, Republic of
GlaxoSmithKline

Completed

Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors

Solid Tumor Cancer

United States
GlaxoSmithKline

Completed

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

Lymphoma | Solid Tumor Cancer

United States
GlaxoSmithKline

Completed

First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050

Diabetes Mellitus, Type 2

United States
Changhai Hospital
Chinese PLA General Hospital

Recruiting

Magnetically Controlled Capsule Endoscopy in Visualization of the UGI and Small Intestine

Stomach Diseases | Small Intestine Disease

China
Taipei Medical University

Unknown

A Phase I Study of SB Cell for the Enhanced Osseointegration of Guided Bone Regeneration in Implant Surgery

Guided Bone Regeneration

Taiwan
Cytokinetics

Completed

A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma

Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States, Russian Federation
GlaxoSmithKline

Completed

Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

Melanoma

Australia, United States

Search clinical trials for: SB-742457 35mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations